Direct-to-patient (DTP) distribution of clinical supplies provides trial sponsors with the opportunity to support improved recruitment and retention rates for their studies by removing or reducing the travel and time commitments that can otherwise inhibit patients’ willingness and ability to participate.
This webinar reveals results from a recent industry survey that sought to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so.
Topics to be discussed include:
- Findings among survey respondents around the value of being able to offer DTP, potential approaches and possible challenges
- Overview of regulatory considerations surrounding DTP in the US and Europe and suggestions on how to create an optimized supply strategy.
- Review of DTP distribution models including a new regulatory compliant, streamlined approach that bypasses the clinical site